Previous 10 | Next 10 |
Prestige Consumer Healthcare (PBH) prices an upsized offering of $600M in aggregate principal amount of 3.750% senior notes due 2031 in a private offering. The sale of the notes is expected to be completed on or about March 1, 2021. Net proceeds from the offering, together with cash on h...
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “ Company ”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“ Prestige Brands ”), has priced an upsized offering of $600 millio...
Prestige Consumer Healthcare's (PBH) wholly-owned subsidiary Prestige Brands intends to offer up to $500M in principal amount of new senior notes due 2031 in a private offering.Net proceeds along with cash on hand and available liquidity will be used to redeem all $600M of Prestige Brands' ou...
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “ Company ”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“ Prestige Brands ”), intends to offer, subject to market and other...
The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Prestige Consumer Healthcare Inc. 2021 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. Prestige Consumer Healthcare Inc (NYSE: PBH) Q3 2021 Earnings Call Feb 4, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Prestige Consumer Healthcare Inc (PBH) Q3 2021 Earnings Call T...
Prestige Consumer Healthcare Inc. (PBH) Q3 2021 Earnings Conference Call February 4, 2021 08:30 ET Company Participants Phil Terpolilli - Head of Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Parti...
Prestige Consumer Healthcare (PBH): FQ3 GAAP EPS of $0.81 beats by $0.04.Revenue of $238.78M (-1.1% Y/Y) beats by $7.23M.Press Release For further details see: Prestige Consumer Healthcare EPS beats by $0.04, beats on revenue
Revenue was $238.8 Million in Third Quarter Fiscal 2021 Diluted EPS of $0.81 in Third Quarter Fiscal 2021 Net Cash Provided by Operating Activities for First Nine Months of Fiscal 2021 Increased 10% to $176.5 million Raising Full-Year Fiscal 2021 Outlook for Revenue and Earnin...
Tuesday is shaping up to be a good day for shareholders of STAAR Surgical (NASDAQ: STAA) , which manufactures implantable lenses, and Prestige Consumer Healthcare (NYSE: PBH) , which markets over-the-counter (OTC) healthcare products. As of 1:30 p.m. EST today, STAAR Surgica...
News, Short Squeeze, Breakout and More Instantly...
Prestige Consumer Healthcare Inc. Company Name:
PBH Stock Symbol:
NYSE Market:
Prestige Consumer Healthcare Inc. Website:
Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding Currency Diluted EPS of $1.02 for Q2, ahead of expectations Reduced Debt by $35 million in Q2 and Achieved Leverage Ratio of 3.7x Reaffirming Full-Year Fiscal 2023 Revenue an...
TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November 3, 2022 before the opening of the market. The Company will host a conference call to discu...
Presentation Times and Weblinks Released for Over 100 Presenting Companies Wednesday and Thursday, September 21-22, 2022 NEW YORK, NY / ACCESSWIRE / September 20, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day September Small-...